Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.
North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%.
The global Liposome Drug Delivery (Liposomes Drug Delivery) market is valued at 2600 million US$ in 2018 is expected to reach 6040 million US$ by the end of 2025, growing at a CAGR of 12.8% during 2019-2025.
This report focuses on Liposome Drug Delivery (Liposomes Drug Delivery) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liposome Drug Delivery (Liposomes Drug Delivery) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Table of Contents
Executive Summary
1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Overview
1.1 Product Overview and Scope of Liposome Drug Delivery (Liposomes Drug Delivery)
1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Type
1.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Application
1.3.1 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Comparison by Application (2014-2025)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market by Region
1.3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size
1.4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue (2014-2025)
1.4.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production (2014-2025)
2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Competition by Manufacturers
2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Manufacturers (2014-2019)
2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Share by Manufacturers (2014-2019)
2.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites, Area Served, Product Types
2.5 Liposome Drug Delivery (Liposomes Drug Delivery) Market Competitive Situation and Trends
2.5.1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Concentration Rate
2.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Regions
3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Regions
3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Regions (2014-2019)
3.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Liposome Drug Delivery (Liposomes Drug Delivery) Production
3.4.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate (2014-2019)
3.4.2 North America Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Production
3.5.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate (2014-2019)
3.5.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Liposome Drug Delivery (Liposomes Drug Delivery) Production (2014-2019)
3.6.1 China Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate (2014-2019)
3.6.2 China Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Production (2014-2019)
3.7.1 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate (2014-2019)
3.7.2 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Regions
4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Regions
4.2 North America Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2014-2019)
4.3 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2014-2019)
4.4 China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2014-2019)
4.5 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2014-2019)
5 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price Trend by Type
5.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Type (2014-2019)
5.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Type (2014-2019)
5.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Price by Type (2014-2019)
5.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth by Type (2014-2019)
6 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Analysis by Applications
6.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2014-2019)
6.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Liposome Drug Delivery (Liposomes Drug Delivery) Business
7.1 Gilead Sciences
7.1.1 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.1.3 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Pacira
7.2.1 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.2.3 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.3.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.3.3 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.4.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.4.3 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Luye Pharma
7.5.1 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.5.3 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.6.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.6.3 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Ipsen (Onivyde)
7.7.1 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.7.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.7.3 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 CSPC
7.8.1 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.8.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.8.3 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.9.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.9.3 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Novartis
7.10.1 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Production Sites and Area Served
7.10.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Introduction, Application and Specification
7.10.3 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Fudan-Zhangjiang
8 Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Cost Analysis
8.1 Liposome Drug Delivery (Liposomes Drug Delivery) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Liposome Drug Delivery (Liposomes Drug Delivery)
8.4 Liposome Drug Delivery (Liposomes Drug Delivery) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Liposome Drug Delivery (Liposomes Drug Delivery) Distributors List
9.3 Liposome Drug Delivery (Liposomes Drug Delivery) Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors
11 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast
11.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast
11.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Growth Rate Forecast (2019-2025)
11.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Price and Trend Forecast (2019-2025)
11.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Forecast by Regions (2019-2025)
11.2.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast (2019-2025)
11.2.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast (2019-2025)
11.2.3 China Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast (2019-2025)
11.2.4 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue Forecast (2019-2025)
11.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast by Regions (2019-2025)
11.3.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2019-2025)
11.3.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2019-2025)
11.3.3 China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2019-2025)
11.3.4 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2019-2025)
11.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast by Application (2019-2025)
Summary: Get latest Market Research Reports on Liposome Drug Delivery (Liposomes Drug Delivery) . Industry analysis & Market Report on Liposome Drug Delivery (Liposomes Drug Delivery) is a syndicated market report, published as Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Research Report 2019. It is complete Research Study and Industry Analysis of Liposome Drug Delivery (Liposomes Drug Delivery) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.